Showing 1 - 17 results of 17 for search 'Daniel F Sahm', query time: 0.04s Refine Results
  1. 1
    Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future

    Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future by Mark M. Huycke, Daniel F. Sahm, Michael S. Gilmore

    Published 1998-06-01
    Get full text
    Article
  2. 2
    Factors Influencing Fluoroquinolone Resistance

    Factors Influencing Fluoroquinolone Resistance by Daniel F. Sahm, Clyde Thornsberry, Mark E. Jones, James A. Karlowsky

    Published 2003-12-01
    Get full text
    Article
  3. 3
    Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019

    Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019 by James A. Karlowsky, Sibylle H. Lob, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2021-03-01
    Get full text
    Article
  4. 4
    Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

    Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015 by James A. Karlowsky, Daryl J. Hoban, Meredith A. Hackel, Sibylle H. Lob, Daniel F. Sahm

    Published 2017-05-01
    Get full text
    Article
  5. 5
    Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.

    Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program. by Mark G Wise, Mark A Estabrook, Daniel F Sahm, Gregory G Stone, Krystyna M Kazmierczak

    Published 2018-01-01
    Get full text
    Article
  6. 6
    Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

    Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in L... by Mark G. Wise, James A. Karlowsky, Elkin V. Lemos-Luengas, Rafael R. Valdez, Daniel F. Sahm

    Published 2023-05-01
    Get full text
    Article
  7. 7
    In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

    In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance... by James A. Karlowsky, Sibylle H. Lob, Krystyna M. Kazmierczak, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2020-06-01
    Get full text
    Article
  8. 8
    Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020

    Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020 by James A. Karlowsky, Samuel K. Bouchillon, Amina Benaouda, Nabila Soraa, Khalid Zerouali, Naglaa Mohamed, Taha Alami, Daniel F. Sahm

    Published 2022-09-01
    Get full text
    Article
  9. 9
    Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

    Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance T... by Sibylle H. Lob, Mark A. Estabrook, C. Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2022-12-01
    Get full text
    Article
  10. 10
    In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020

    In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020 by James A. Karlowsky, Sibylle H. Lob, Fakhar Siddiqui, Jacqueline Pavia, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2023-05-01
    Get full text
    Article
  11. 11
    In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2019

    In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2... by Sibylle H. Lob, Krystyna M. Kazmierczak, Wei-Ting Chen, Fakhar Siddiqui, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2022-06-01
    Get full text
    Article
  12. 12
    In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018

    In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE... by James A. Karlowsky, Meredith A. Hackel, Samue l K. Bouchillon, Warren Lowman, Ramy El Mahdy Kotb, Naglaa Mohamed, Gregory G. Stone, Daniel F. Sahm

    Published 2021-03-01
    Get full text
    Article
  13. 13
    Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan—SMART 2012–2021

    Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan—SMART 2012–2021... by James A. Karlowsky, Mark G. Wise, Tai-Chin Hsieh, Hung-Chi Lu, Wei-Ting Chen, Ming-Huei Cheng, Fakhar Siddiqui, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2023-09-01
    Get full text
    Article
  14. 14
    Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000

    Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 by Ian A. Critchley, Renée S. Blosser, James A. Karlowsky, Juri Yamakita, Alfonso Barth, Helio S. Sader, Caio Mendes, Lucia Teixeira, Flavia Rossi, Cicero A. C. Dias, Mark E. Jones, Clyde Thornsberry, Daniel F. Sahm

    Get full text
    Article
  15. 15
    In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021

    In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–... by Mark G. Wise, James A. Karlowsky, Meredith A. Hackel, Mohamed Amine Harti, Bontle M.E. Ntshole, Eva Njeri Njagua, Rita Oladele, Catherine Samuel, Shameema Khan, Jeannette Wadula, Warren Lowman, Busisani W. Lembede, Daniel F. Sahm

    Published 2023-12-01
    Get full text
    Article
  16. 16
    In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

    In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa by Katherine Young, Ronald E. Painter, Susan L. Raghoobar, Nichelle N. Hairston, Fred Racine, Douglas Wisniewski, Carl J. Balibar, Artjohn Villafania, Rumin Zhang, Daniel F. Sahm, Timothy Blizzard, Nicholas Murgolo, Milton L. Hammond, Mary R. Motyl

    Published 2019-07-01
    Get full text
    Article
  17. 17
    Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017–2020

    Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017–2020 by James A. Karlowsky, Sibylle H. Lob, Tsz K. Khan, Wei-Ting Chen, Patrick C.Y. Woo, Wing Hong Seto, Margaret Ip, Stanley W.M. Leung, Queenie W.-L. Wong, Rene W.Y. Chau, C. Andrew DeRyke, Katherine Young, Mary R. Motyl, Daniel F. Sahm

    Published 2023-06-01
    Get full text
    Article

Search Tools: